CSPC Pharmaceutical Group Limited (HKG:1093)
9.89
+0.16 (1.64%)
Jan 21, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of 111.24 billion as of January 21, 2026. Its market cap has increased by 101.53% in one year.
Market Cap
111.24B
Enterprise Value
102.94B
Revenue
28.65B
Ranking
n/a
PE Ratio
25.13
Stock Price
9.89
Market Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 696.00M to 111.24B, an increase of 15,883.27%. That is a compound annual growth rate of 18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 111.24B | 15.42% |
| Dec 31, 2025 | 96.38B | 74.70% |
| Dec 31, 2024 | 55.17B | -35.87% |
| Dec 29, 2023 | 86.02B | -11.96% |
| Dec 30, 2022 | 97.71B | -3.19% |
| Dec 31, 2021 | 100.93B | 6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| Akeso | 111.46B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.48B |